Based on a more than 10 years
experience EPO offers a broad spectrum of methods for preclinical testing of
potential drug candidates for cancer.
EPO provides services for:
Testing
in vivo
Testing
in vitro
Tumourigenicity testing
Metastasis models
Drug
resistance models
Stem cell
research
Target
identification and validation
Drug
formulation
EPO uses SOPs of established and validated methods and continuously extents the panel of offers to be at the state of the art.
EPO
works in a customer-related way concerning experimental design and
evaluation.
Copyright © 2007 of EPO GmbH - All rights reserved. 17.03.2008